PhaseBio

+$0.14 (+4.58%) Today
$0.00 (0.00%) As of 8:14 PM UTC after-hours

Why Robinhood?

You can buy or sell PhaseBio and other stocks, options, and ETFs commission-free!

About PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock, also called PhaseBio, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiopulmonary diseases.

CEO
Jonathan P. Mow
Employees
50
Headquarters
Malvern, Pennsylvania
Founded
2002

PHAS Key Statistics

Market Cap
149.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
490.12K
High Today
$3.26
Low Today
$3.04
Open Price
$3.06
Volume
262.36K
52 Week High
$6.85
52 Week Low
$2.60

PHAS Earnings

-$1.03
-$0.69
-$0.34
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.69 per share
Actual
-$0.87 per share

You May Also Like

FLIC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure